| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Inds. | Pharmaceuticals& Drugs | 1,824.1 |
15.9 (0.88%) |
Large Cap | 52,578 | 45.5 | 21.55 | 40.1 | 5.4 | |
| Cipla | Pharmaceuticals& Drugs | 1,334.9 |
24.95 (1.9%) |
Large Cap | 27,548 | 56.3 | 18.76 | 23.7 | 3.2 | |
| Torrent Pharma | Pharmaceuticals& Drugs | 4,252.1 |
60.55 (1.44%) |
Large Cap | 11,516 | 67.1 | 16.73 | 63.3 | 15.8 | |
| Divis Lab | Pharmaceuticals& Drugs | 6,618.2 |
112.85 (1.73%) |
Large Cap | 9,360 | 93.4 | 23.08 | 70.9 | 11 | |
| Apollo Hospital Ent. | Hospital &HealthcareServices | 7,738.1 |
98.85 (1.29%) |
Large Cap | 8,202 | 100.4 | 15.81 | 77.1 | 11.5 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: